Literature DB >> 238929

Inherited susceptibility of cattle to high-altitude pulmonary hypertension.

D H Will, J L Hicks, C S Card, A F Alexander.   

Abstract

This study examines the hypothesis that susceptibility of cattle to high-altitude pulmonary hypertension and heart failure (high mountain disease) is genetically transmitted. Eight offspring of cattle recovered from high mountain disease were considered "susceptible." Eleven offspring of healthy cattle residing at high altitude were considered "resistant." At the resident altitude of 1,524 m, 10-day-old susceptible calves had higher pulmonary arterial pressures than did resistant calves (34 vs.21 mmHg), but at 90 days of age the pressures for the two groups were similar (26 vs. 24 mmHg). After 64 days of exposure to an altitude of 3,048 m, the susceptible calves (87 +/- 7 (SE) vs. 40 +/- 3 mmHg). By 124 days at 3,048 m, all susceptible but none of the resistant calves had developed heart failure. The results indicated that susceptibility to pulmonary hypertension at high altitude was inherited. Susceptible cattle may provide a useful model of human hypoxic pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238929     DOI: 10.1152/jappl.1975.38.3.491

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  15 in total

1.  Hemodynamic and ventilatory effects of skin-cooling in cattle.

Authors:  I F McMurtry; J T Reeves; D H Will; R F Grover
Journal:  Experientia       Date:  1975-11-15

2.  Investigation of congestive heart failure in beef cattle in a feedyard at a moderate altitude in western Nebraska.

Authors:  Rodney A Moxley; David R Smith; Dale M Grotelueschen; Tom Edwards; David J Steffen
Journal:  J Vet Diagn Invest       Date:  2019-06-06       Impact factor: 1.279

3.  Myosin heavy chain 15 is associated with bovine pulmonary arterial pressure.

Authors:  Marianne T Neary; Joseph M Neary; Gretchen K Lund; Timothy N Holt; Franklyn B Garry; Timothy J Mohun; Ross A Breckenridge
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 4.  Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine.

Authors:  Kimberly J Dunham-Snary; Danchen Wu; Edward A Sykes; Amar Thakrar; Leah R G Parlow; Jeffrey D Mewburn; Joel L Parlow; Stephen L Archer
Journal:  Chest       Date:  2016-09-16       Impact factor: 9.410

5.  The yak genome and adaptation to life at high altitude.

Authors:  Qiang Qiu; Guojie Zhang; Tao Ma; Wubin Qian; Junyi Wang; Zhiqiang Ye; Changchang Cao; Quanjun Hu; Jaebum Kim; Denis M Larkin; Loretta Auvil; Boris Capitanu; Jian Ma; Harris A Lewin; Xiaoju Qian; Yongshan Lang; Ran Zhou; Lizhong Wang; Kun Wang; Jinquan Xia; Shengguang Liao; Shengkai Pan; Xu Lu; Haolong Hou; Yan Wang; Xuetao Zang; Ye Yin; Hui Ma; Jian Zhang; Zhaofeng Wang; Yingmei Zhang; Dawei Zhang; Takahiro Yonezawa; Masami Hasegawa; Yang Zhong; Wenbin Liu; Yan Zhang; Zhiyong Huang; Shengxiang Zhang; Ruijun Long; Huanming Yang; Jian Wang; Johannes A Lenstra; David N Cooper; Yi Wu; Jun Wang; Peng Shi; Jian Wang; Jianquan Liu
Journal:  Nat Genet       Date:  2012-07-01       Impact factor: 38.330

6.  Relation of TXA2 and PGI2 to the difference in hypoxic pulmonary vasoconstriction between different strains of rats.

Authors:  Y C Su; X R Jin
Journal:  J Tongji Med Univ       Date:  1989

7.  Contribution of polycythaemia to pulmonary hypertension in simulated high altitude in rats.

Authors:  G R Barer; D Bee; R A Wach
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

8.  Pulmonary arterial hypertension in male and female chickens at 3300 m.

Authors:  A H Sillau; S Cueva; P Morales
Journal:  Pflugers Arch       Date:  1980-08       Impact factor: 3.657

Review 9.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

10.  A Review of Transcriptome Analysis in Pulmonary Vascular Diseases.

Authors:  Dustin R Fraidenburg; Roberto F Machado
Journal:  Methods Mol Biol       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.